1. Introduction
Ciliated human nasal epithelial cells (c-hNECs) have been differentiated from human nasal epithelia (operation samples) using air–liquid interface (ALI) culture. Inhaled small particles, such as chemicals, allergens, bacteria and viruses, are trapped by the surface mucous layer of the nasal epithelium and swept away from the nasal cavity by the beating cilia [
1,
2,
3,
4]. Impairment of the nasal beating cilia, such as primary ciliary dyskinesia, causes sinusitis [
1,
2,
4]. Thus, beating cilia play a crucial role in maintaining a healthy nasal cavity [
1,
3,
4,
7]. Activities of the airway beating cilia are controlled by various substances, such as cAMP, cGMP, Ca
2+, H
+ and Cl
- [
2,
4,
5,
6,
7,
8,
9,
10]. Among them, the H
+ is an important regulator of airway beating cilia; an increase in intracellular pH (pH
i) enhances the ciliary beat frequency (CBF) and ciliary bend distance (CBD, an index of ciliary beat amplitude (CBA)); contrarily, a decrease in pH
i suppresses them [
6,
8,
9,
10].
The ciliated nasal epithelium is a special tissue, the apical surface of which is periodically exposed to fresh air with respiration. The temperature and CO
2 concentration of air are different from those of gas existing in the trachea and lung airways. The c-hNECs have been shown to express thermosensitive transient receptor potentials (TRP) A1 and M8, which keep the ciliary beating at an adequate level in cooled air [
11]. Moreover, the CO
2 concentration (0.04%) of air is significantly lower than that of blood or interstitial fluid (5%). Periodic air exposure (0.04% CO
2) appears to increase the pH
i, leading to a CBF increase, as shown in tracheal and lung airway ciliated cells upon applying the CO
2/HCO
3--free solution (Zero-CO
2) [
8,
9,
10]. However, a previous study demonstrated that the application of Zero-CO
2 does not increase the pH
i, CBF or CBD in c-hNECs [
6]. Moreover, the application of NH
4+ pulse induced gradual decreases in pH
i and CBF following their immediate increases. The gradual decreases in pH
i and CBF were inhibited by acetazolamide (a carbonic anhydrase (CA) inhibitor) [
6]. These findings indicate that H
+ is produced from CO
2 by the CA-mediated reaction (Eq. 1), even during the application of Zero-CO
2 in c-hNECs.
However, the factors, which shift the Eq. 1 to the right (H+ production) upon applying Zero-CO2 or the NH4+ pulse, remain unidentified in c-hNECs.
A previous study showed that carbonic anhydrase IV (CAIV) is expressed in nasal epithelia [
12,
13]. However, the role of CAIV is not fully understood in nasal epithelia, especially in beating cilia. Previous studies have also demonstrated that CAIV interacts with Na
+-HCO
3- cotransporter (NBC) in HEK293 cells transfected with CAIV and NBC [
14], renal proximal tubules [
15] and retinal epithelium [
16]. Nasal epithelia have also been shown to express NBC [
17]. CAIV may interact with NBC in c-hNECs.
We hypothesized that the interactions between CAIV and NBC maximize the rate of HCO
3- influx in c-hNECs, leading to a high pH
i. The high pH
i (low [H
+]
i) may shift the Eq.1 to the right, inducing no increase in CBF or CBD, even upon applying Zero-CO
2, and inducing their gradual decreases during application of the NH
4+ pulse. We also used ciliated human bronchial epithelial cells (c-hBECs), which were differentiated from normal human bronchial epithelial cells (NHBE) using ALI culture [
18]. We found that c-hBECs, similar to c-hNECs, express CAs except CAIV, NBCs and anion exchangers (AEs). The c-hBECs appear to provide a good model of airway ciliated cells expressing no CAIV. The goal of this study is to clarify the CAIV-mediated mechanism, which suppresses increases in CBF, CBD and pH
i in c-hNECs upon applying Zero-CO
2.
3. Discussion
The present study demonstrated that the pHi of c-hNECs is extremely high (7.66) and that the high pHi is generated by a high rate of HCO3- influx in c-hNECs. The [HCO3-]i is calculated to be 41.4 mM from pHi (7.66) and pCO2 (5% CO2, 38 mmHg) using the Henderson–Hasselbalch equation in c-hNECs. This study also demonstrated that the pHi of c-hBECs is low (7.10) and that the low pHi is generated by a low rate of HCO3- influx. The [HCO3-]i is calculated to be 11.4 mM from the pHi (7.1) and pCO2 (38 mmHg) in c-hBECs. The [HCO3-]i of c-hNECs is approximately four times higher than that of c-hBECs.
The high level of pH
i caused a decrease or a small increase in pH
i upon applying Zero-CO
2 in c-hNECs, leading to a decrease or small increase in CBF. Similar results have already been shown in c-hNECs [
6]. As shown above, the pH
i and [HCO
3-]
i were extremely high in c-hNECs in the control solution, and the switch to Zero-CO
2 decreased [HCO
3-]
i due to there being no HCO
3- entry. An extremely high pH
i (low [H
+]
i) and a low [HCO
3-]
i appear to shift the Eq.1 to the right (H
+ production) even in the Zero-CO
2, in which a small amount of CO
2 is supplied via cellular metabolism. A decrease in pH
i caused CBF and CBD to decrease in c-hNECs [
8,
9]. However, in the c-hBECs, the pH
i and [HCO
3-]
i were low due to there being a low rate of HCO
3- influx. Under this condition, the switch to Zero-CO
2, which decreases the CO
2 concentration while keeping a low pH
i (a high [H
+]
i) and low [HCO
3-]
i, shifts the Eq. 1 to the left to increase the pH
i (CO
2 production from H
+). This pH
i increase enhances CBF and CBD in c-hBECs [
8,
9]. Thus, an extremely high pH
i is the key factor in shifting the Eq. 1 to the right upon applying Zero-CO
2 in c-hNECs.
The application of Zero-CO2 appears to induce a large decrease in [HCO3-]i in c-hNECs. The effects of the decrease in [HCO3-]i on Eq.1 may be much larger than those of the decrease in [CO2]i in c-hNECS upon applying Zero-CO2. In c-hBECs, however, the application of Zero-CO2 decreases [CO2]i to an extremely low level and may induce little decrease in [HCO3-]i because of a low HCO3- influx rate. The effects of the decrease in [CO2]i on the Eq. 1 may be much larger than those of the [HCO3-]i decrease in c-hBECs, inducing the left shift upon applying Zero-CO2.
The high rate of HCO3- transport into cells is maintained in c-hNECs, leading to an extremely high pHi. RT-PCR analysis revealed that NBC (NBC1, NBCe1, NBCe2, NBCn1 and NDCBE) and AE (SLC4A2 (AE2)) are expressed in both c-hNECs and c-hBECs. The present study demonstrated that NBC blockers (S0859 and DIDS) decrease CBF in c-hNECs, but that they do not change CBF in c-hBECs. Thus, the activity of NBC is high in c-hNECs, but not in c-hBECs. This indicates that the mechanism stimulating NBC activity exists in c-hNECs.
The contribution of AEs to HCO
3- entry appears to be small because there was no difference in the CBF decrease induced by S0859 or DIDS in c-hNECs. The Na
+/H
+ exchange (NHE) is unlikely to extrude H
+ from c-hNECs because it has been shown to be inactive at pH
i levels higher than 7.4 [
22].
The present study demonstrated that CAIV is expressed in c-hNECs, but not in c-hBECs. The expression of CAIV has already been shown in human nasal epithelia [
13]. A previous study demonstrated that the physical and functional interactions between CAIV and NBC maximize transmembrane HCO
3- transport in HEK239 cells transfected with NBC1b and CAIV [
14]. The C-terminal tail of CAIV is anchored in the outer surface of the plasma membrane, and a physical interaction between extracellular CAIV and NBC1 occurs via the fourth extracellular loop of NBC1 [
14]. In the basolateral membrane of renal proximal tubules, CAIV, which colocalizes with NBC1, increases NBC1 activity [
15]. The R14W mutation of CAIV, which has been detected in an autosomal dominant form of retinitis pigmentosa, impairs the pH balance in photoreceptor cells by affecting HCO
3- influx [
16]. These findings suggest that CAIV interacts with NBC to increase the activity of HCO
3- transport in the c-hNECs. Ciliated-hBECs express HCO
3- transporters, but no CAIV. A previous report showed that the expression of CAIV was low in the trachea [
26]. The NBC blocker study exhibited that the activity of NBC is low in c-hBECs, as described above. Moreover, c-hBECs kept a low pH
i. These indicate that no expression of CAIV causes low NBC activity in c-hBECs. These results indicate that CAIV increases the NBC activity to maximize the rate of HCO
3- transport into cell in c-hNECs.
CAII has been shown to interact with NBC1 [
21,
23,
26]. CAII and CAIV have similar structures, and the acid motif in the NBC1 C-terminal region interacts with the basic N-terminal region of CAII [
21,
27]. The HCO
3-s are produced by CAIV on the apical surface and enter cells via NBCs, and the HCO
3- in the cells is converted to CO
2 by CAII just below the apical membrane. The coupling of CAIV-NBC-CAII potentiates transmembrane HCO
3- influxes in c-hNECs [
20,
21]. In this study, brinzolamide (CAII inhibitor) and dorzolamide (CAII and CAIV inhibitor) showed similar decreases in CBF and pH
i. These results suggest that the interactions of CAIV, NBC and CAIV potentiate the influx of HCO
3- in c-hNECs. The CAIV, NBC and CAII have been shown to compose the bicarbonate transport metabolon in renal proximal tubules [
14,
15,
20,
21]. The c-hNECs also appear to express the bicarbonate transport metabolon consisting of CAIV-NBC-CAII, which maximizes the rate of HCO
3- transport from the apical surface into the cell.
Kim et al. (2008) showed that eleven CA isozymes are expressed in whole tissue of normal human nasal mucosa using RT-PCR [
13]. The activity levels of CAIII and CAXIV are known to be low compared with those of CAI, CAII, CAIV and CAVb [
24,
25,
28]. The present study demonstrated that c-hNECs express mRNA of CAI, CAII, CAIII, CAIV and CAVb, and that CAIV protein, a secreted CA isozyme, is localized on the apical surface including cilia. Brinzolamide (a selective CAII inhibitor) abolished the decreases in CBF and pH
i upon applying Zero-CO
2 and the NH
4+ pulse. This suggests that CAII is essential for the HCO
3- transport metabolon in c-hNECs.
The present study does not provide the localization of NBC isoforms in the apical membrane of c-hNECs. However, it has been demonstrated that NBC1 and CAIV have a physical and functional relationship in HEK293 cells transfected with NBC1 and CAIV [
14,
20,
21]. Liu et al. (2022) also showed that NBC functionally exists in apical membranes of mice bronchioles [
29]. The present study suggests that NBC1 exists in the apical membrane of c-hNECs, forming the bicarbonate transport metabolon.
The application of Zero-CO
2 induced various responses in CBF and pH
i, either decreases (
Figure 5) or small increases (
Figure 6A) [
7], although it never induced large increases as shown in c-hBECs (
Figure 10) or bronchial ciliated cells [
9]. Before measuring the CBF or pH
i, c-hNECs with a permeable support filter were kept in the control solution at room temperature. The conditions of c-hNECs were maintained until experimental conditions, such as the time and temperature, affected the pH
i and CBF. Keeping cells at 4° C in air more than 3 hrs, the pH
i decreased by approximately 0.1–0.15, and at this decreased pH
i, the application of Zero-CO
2 induced no changes or slight increases in pH
i and CBF in c-hNECs.
In this study, two types of nasal tissue (uncinate process and nasal polyp) were resected from 16 patients who required surgery for CS. We measured CBF in c-hNECs differentiated from two cell types of nasal epithelia. The CBFs of c-hNECs obtained from two types of nasal tissue were similar. Moreover, c-hNECs obtained from two types of nasal tissue expressed the CAIV mRNA. Kim et al. showed that the expression levels of eleven CA isozymes were decreased by 80–40% in the nasal polyp [
13]. However, they examined mRNA expression using whole samples, and the expression of CA isozymes in nasal polyp was weak in the epithelial layer, but weaker or absent in submucosal glands and vascular endothelial cells. We used c-hNECs cultured using ALI, which contain no submucosal gland and no vascular endothelial cells. Based on these observations, CAII and CAIV, at least, express and function in c-hNECs obtained from nasal polyp samples, although the expression level may be lower than in normal nasal epithelia.
We used c-hBECs obtained using ALI culture from NHBEs as a model of human tracheal epithelia. The NHBEs were bought from Lonza (Lot No. 20TL119094). The c-hBECs used appear to provide a good model of tracheal ciliated epithelial cells, although the NHBEs are not the operation sample.
Ciliated-hNECs were cultured in the ALI with 5% CO
2 for more than 4 weeks. The culture condition with 5% CO
2 is different from the asymmetrical gas condition of c-hNECs and c-hBECs in vivo; the apical surface is exposed to the air (0.04% CO
2) periodically and the basolateral membranes are exposed to interstitial fluid saturated with 5% CO
2 (
Figure 12). The ALI with 5% CO
2 enhances the HCO
3- transport into c-hNECs. This unphysiological gas condition appears to increase the pH
i to an extremely high level by maximizing HCO
3- transport via the bicarbonate transport metabolon CAIV-NBC-CAII (
Figure 12A). In c-hBECs that expressed no CAIV, CO
2 that entered the cells is converted to H
+ and HCO
3- by CAII. The H
+ produced stays in c-hBECs, decreasing the pH
i, while HCO
3- is secreted to the lumen. Thus, the ALI culture condition may enhance HCO
3- entry in c-hNECs and CO
2 entry in c-hBECs, leading to a high pH
i in c-hNECs and a low pH
i in c-hBECs.
In conclusion, we identified a novel bicarbonate transport metabolon consisting of CAIV, NBC and CAII, which regulates pH
i in c-hNECs. In the physiological condition, CO
2 diffuses to the apical surface from the interstitial space according to the CO
2 gradient between interstitial fluid (5%) and air (0.04%). The leaked CO
2 is converted to H
+ and HCO
3- by CAIV. The HCO
3- enters cells via NBC, and the H
+ stays in the nasal surface mucous layer, maintaining a low pH. A low pH in the nasal mucous layer is essential for maintaining a healthy nasal cavity capable of, for instance, providing protection from inhaled bacteria [
30,
31] (
Figure 12B). The HCO
3- that entered the cells is immediately removed by CAII, producing CO
2. The removal of HCO
3- by CAII enables the continuous transportation of HCO
3- into the cell by keeping the driving force for HCO
3- entry. Although we do not know the exact pCO
2 and [HCO
3-]
i of nasal ciliary cells periodically exposed to air, the HCO
3- transport metabolon appears to be essential for maintaining pH
i and ciliary beating of c-hNECs at adequate levels in the air. The bicarbonate transport metabolon (CAIV-NBC-CAII), which controls the transmembrane influx of HCO
3-, appears to be essential for controlling the CBF and pH
i in c-hNECs. Further studies are required to understand this novel mechanism in nasal epithelia in vivo.
4. Materials and Methods
4.1. Ethical Approval
This study has been approved by the ethical committees of the Kyoto Prefectural University of Medicine (RBMR-C-1249-7) and Ritsumeikan University (BKC-HM-2020-090). All experiments were performed in accordance with the ethical principles for medical research outlined in the Declaration of Helsinki (1964) and its subsequent revisions (
https://www.wma.net/). Informed consent was obtained from all patients before operation. Human nasal tissue samples (nasal polyp or uncinate process) were resected from patients who required surgery for chronic sinusitis (16 patients). Samples were immediately cooled and stored in the cooled control solution (4°C) until cell isolation [
6].
4.2. Solution and Chemicals
The control solution contained 121 mM of NaCl, 4.5 mM of KCl, 25 mM of NaHCO3, 1 mM of MgCl2, 1.5 mM of CaCl2, 5 mM of NaHEPES, 5 mM of HHEPES and 5 mM of glucose. Its pH was adjusted to 7.4 using HCl (1 M), and the solution was aerated with 95% O2 and 5% CO2. The CO2/HCO3--free control solution was prepared by replacing NaHCO3 in the control solution with NaCl and was aerated with 100% O2. To apply the NH4+ pulse, the NaCl (25 mM) in solutions was replaced with NH4Cl (25 mM). DNase I, amphotericin B, DIDS (4,4-Diisothiocyanatostilbene-2,2-disulfonic acid disodium salt hydrate) and S0859 (a selective NBC inhibitor, 2-chloro-N-((2′-(N-cyanosulfamoyl)-[1,1′-biphenyl]-4-yl)methyl)-N-(4-methylbenzyl) benzamide) were purchased from Sigma-Aldrich (St Louis, MO, USA). Dorzolamide and brinzolamide were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Can Get Signal® Immunoreaction Enhancer Solution was purchased from TOYOBO (Osaka, Japan).
4.3. Cell Culture Media
Complete PneumaCultTM-Ex Plus medium contained PneumaCultTM-Ex Plus Basal Medium supplemented with PneumaCultTM-Ex supplement (50×, 20 µL/mL), hydrocortisone stock solution (1 µL/mL) and penicillin and streptomycin solution (10 µL/mL). Complete PneumaCultTM-ALI medium contained PneumaCultTM-ALI basal medium supplemented with PneumaCultTM-ALI supplement (10×, 100 µL/mL), PneumaCltTM-ALI maintenance supplement (10 µL/mL), heparin solution (2 µL/mL), hydrocortisone stock solution (2.5 µL/mL) and penicillin/streptomycin solution (10 µL/mL). Solutions and supplements were purchased from STEMCELL Technologies, INC. (Vancouver, BC, Canada). Elastase, bovine serum albumin (BSA) and dimethyl sulfoxide (DMSO) were purchased from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). Penicillin/streptomycin mixed solution (penicillin 10000 units/mL and streptomycin 10000 µg/mL in 0.85% NaCl), trypsin, and the trypsin inhibitor were purchased from Nacalai Tesque, Inc. (Kyoto, Japan).
4.4. Antibodies
The anti-CAIV antibody (AF2186, polyclonal goat antibody) was purchased from R&D Systems (Minneapolis, MN, USA). The concentration of MAB2186 used was 1 µg/mL. The antigen peptide (2186-CA, recombinant human CAIV) was also purchased from R&D systems. The anti-alpha-tubulin (acetyl K40) (AC-tubulin) antibody (ab179484) was purchased from Abcam and used at a 100-fold dilution. Alexa Fluor 488 goat anti-mouse IgG (H+L) secondary antibodies (A-11001) and Alexa Fluor 594 donkey anti-rabbit IgG (H+L) secondary antibodies (A-21207) were purchased from Thermo Fischer Scientific (Waltham, MA, USA).
4.5. Cell preparation
We isolated c-hNECs from nasal operation samples as described previously [
6]. Briefly, resected samples were cut into small pieces and incubated for 40 min at 37°C in control solution containing elastase (0.02 mg/mL), DNase I (0.02 mg/mL) and BSA (3%). Then, the samples were minced in control solution containing DNase I (0.02 mg/mL) and BSA (3%) using fine forceps. Isolated nasal cells were washed with control solution containing BSA (3%) three times with centrifugation at 160 ×
g for 5 min and then sterilized for 15 min using amphotericin B (0.25 μg/mL) in Ham’s F-12 with L-glutamine. Isolated nasal epithelial cells were cultured in complete PneumaCult-Ex medium in a collagen-coated flask (Corning, 25cm
2, NY 14831 USA) at 37°C in a humidified 5% CO
2 atmosphere. The medium was changed every second day. Once the cells reached confluency, they were washed with PBS (5 mL) and harvested in Hank’s balanced salt solution (HBSS, 2 mL) containing 0.1 mM EGTA and 0.025% trypsin to remove cells from the flask. Then, a trypsin inhibitor was added into the cell suspension to stop further digestion. After washing with centrifugation, cells were resuspended in complete PneumaCultTM-Ex Plus medium (1–2 × 10
5 cells, 3mL) and seeded on a filter of a Transwell permeable support insert (Coster 3470, 6.5 mm Transwell with 0.4 μm Pore Polyester Membrane Inserts, Corning) (3.0 × 10
4 cells/insert, 400 μL). Complete PneumaCultTM-Ex Plus medium was added into the upper and bottom chambers and cells were cultured until confluent. Then, the medium in the bottom chamber was replaced with complete PneumaCultTM-ALI medium (500 μL) and the medium in the upper chamber was removed to expose cells to the air (ALI culture). The medium in the bottom chamber was changed three times a week. Cells were cultured for 4 weeks under the ALI condition to allow differentiation into ciliated cells [
6].
NHBE cells were purchased from Lonza (LOT No. 20TL119094, Basel, Switzerland) and cultured in the flask, in which complete PneumaCultTM-Ex Plus medium was added at 37°C in a humidified 5% CO
2 atmosphere. Once the cells had reached confluency, they were washed with PBS (5 mL) and harvested with HBSS (2 mL) containing 0.1 mM EGTA and 0.025% trypsin. Then, a tripsin inhibitor was added. After washing cells with centrifugation, cells were resuspended in complete PneumaCultTM-Ex Plus medium (3 mL). The cells were seeded onto the filter of Transwell permeable support inserts (3.0 × 10
4 cells/insert, 400 μL) and cultured into complete PneumaCultTM-Ex Plus medium, which was also added to the upper and bottom chambers. Once the cells reached confluency, the medium in the bottom chamber was replaced with PneumaCultTM-ALI medium (500 μL) and the medium in the upper chamber was removed (ALI culture). The medium in the bottom chamber was changed three times a week. Cells were cultured for 3 weeks under the ALI condition [
22]. There were no differences in the development of cilia between nasal epithelial and NHBE cells.
4.6. Measurements of CBF and CBD
The insert membrane filter, on which cells had grown, was cut into 4–6 pieces. A piece of membrane with cells was placed on a coverslip precoated with neutralized Cell-Tak (Becton Dickinson Labware, Bedford, MA, USA). The coverslip with cells was then set in a perfusion chamber (20 µL), which was mounted on an inverted microscope (T-2000, NIKON, Tokyo, Japan) connected to a high-speed camera (IDP-Express R2000, Photron Ltd., Tokyo) (high-speed video microscope). The cells were perfused at a constant rate (200 µL/min). Since CBF is sensitive to temperature, the experiments were carried out at 37°C [
5,
6,
7,
9,
10]. Video images were recorded for 2 s at 500 fps using a high-speed video microscope. Video images of c-hNECs before and 5 min after applying NH
4+ pulse are shown in
S1 and S2, respectively. The methods to measure CBF and CBD (ciliary bend distance, an index of ciliary beating amplitude (CBA)) have been described in detail [
5,
6,
7,
9,
10]. The ratios of CBF (CBF
t/CBF
0) and CBD (CBD
t/CBD
0) were calculated to make comparisons across the experiments. The subscripts ‘0’ and ‘t’ indicate the time from the start of the experiments. Cells with the cut filter were kept in the control solution at room temperature (2–3 hrs) until the start of CBF and CBD measurements. The store conditions, such as temperature and time, affected CBF responses upon Zero-CO
2 application, resulting in a decrease, no change or a small increase, as shown in Figuer 5 and 6.
4.7. Measurement of pHi
The insert membrane filter with cells was incubated with a Ca2+-free control solution containing 1 mM EGTA (pH 7.2) for 10 min at room temperature, and the cell sheet was then removed from the membrane filter using a fine forceps. Then, the cell sheet was incubated with 2 µM BCECF-AM (Dojindo Laboratories, Kumamoto, Japan) for 30 min at 37°C. After BCECF loading, the cell sheet was cut into small pieces (4–6 pieces) and kept in the control solution at room temperature until pHi measurements. A piece of cell sheet was set in a perfusion chamber, and the fluorescence of BCECF was measured using an image analysis system (MetaFluor, Molecular Device, USA). BCECF was excited at 440 nm and 490 nm, and the emission was recorded at 530 nm. The fluorescence ratio (F490/F440) was calculated and recorded with the image analysis system. The calibration curve for pHi was obtained using BCECF-loaded cells perfused with a calibration solution containing nigericin (15 µM, Sigma-Aldrich, St Louis, MO, USA). The pH values of calibration solution were 6.5, 7.0, 7.5, and 8.0. The calibration solution contained 150.5 mM of KCl, 2 mM of MgCl2, 1 mM of CaCl2, 10 mM of HEPES and 5 mM of glucose.
4.8. RT-PCR
Total RNA samples from c-hNECs and c-hBECs were prepared using an RNeasy Minikit (QIAGEN, Tokyo, Japan). Total RNA was reverse-transcribed to cDNA using an oligo d(T)6 primer and an Omniscript RT kit (QIAGEN). Then, cDNA samples were subjected to Reverse Transcription-Polymerase Chain Reaction (RT-PCR) using KOD FX (TOYOBO). The gene-specific primers for human CA are listed in
Table 1, and those for human NBC and anion exchangers (AE) are shown in
Table 2. The amplified PCR products were confirmed using agarose gel.
Real-time PCR was performed in c-hNECs and c-hBECs using the cDNA and CAIV primers confirmed using RT-PCR, and the expression levels of CAIV mRNA were quantitatively evaluated. Quantitative analyses for CAIV mRNA expression and GAPDH mRNA expression were performed using the PowerUp SYBR Green Master Mix (Applied Biosystems, Waltham, MA, USA). The expression level of CAIV mRNA was normalized to that of GAPDH.
4.9. Western Blotting
Cells on the insert membrane filter were washed with PBS and removed from the filter. Then, cells were homogenized in a radioimmunoprecipitation assay buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Nonidet-P40, 0.5% sodium deoxycholate and 0.1% SDS, pH 7.6) containing a protease inhibitor cocktail and incubated at 4°C for 20 min. Cells were then centrifuged at 16,000 × g for 20 min at 4°C. The supernatant was used as cell lysate. The lysate was incubated at 37°C overnight with PNGase F (Roche, Basel, Switzerland) in PBS containing 15 mM EDTA, 1% Nonidet P-40, 0.2% SDS and 1% 2-mercaptoethanol. Proteins were separated using Laemmli’s SDS-polyacrylamide gel electrophoresis (8%–12.5%) and then transferred onto a polyvinylidene difluoride membrane. The membrane was blocked with milk (2.5%) in Tris-buffered saline (10 mM Tris-HCl and 150 mM NaCl, pH 8.5) containing 0.1% Tween 20 (TBST) for 1 h and then incubated with a primary antibody (MAB2186, R&D System) diluted in solution 1 (Can Get Signal Immunoreaction Enhancer Solution, TOYOBO) overnight at 4°C. After washing with TBST, the membrane was incubated with a secondary antibody (AP124P, anti-mouse IgG) diluted in solution 2 (Can Get Signal Immunoreaction Enhancer Solution, TOYOBO) for 1 h at room temperature. After washing, antigen–antibody complexes on the membrane were visualized using a chemiluminescence system (ECL plus; GE Healthcare, Waukesha, WI, USA).
4.10. Immunofluorescence Examination
Immunofluorescence examinations were performed in c-hNECs and c-hBECs [
26]. Cells on the Transwell insert membrane filter were removed using a cell scraper and suspended in PBS (2 mL). The cell suspension (0.5 mL) was dropped and dried on the cover slip, to which cells attached. Then, cells were fixed in 4% paraformaldehyde for 30 min and washed three times with PBS containing 10 mM glycine. Cells were permeabilized with 0.1% Triton X-100 for 15 min at room temperature. After 60 min of pre-incubation with PBS containing 3% BSA at room temperature, cells were incubated overnight at 4°C with the anti-CAIV (AF2186) and anti-AC-tubulin (ab179484, Abcam) antibodies. Then, cells were washed with PBS containing 0.1% BSA to remove unbound antibodies. Afterwards, cells were stained with Alexa Fluor 488 goat anti-mouse IgG (H+L) (A-11001, 1:100 dilution) and Alexa Fluor 594 donkey anti-rabbit IgG (H+L) (A-21207, 1:100 dilution) secondary antibodies for 60 min at room temperature. The samples on the coverslip were enclosed with a mounting medium with DAPI (Vector, Burlingame, CA, USA). Cells were observed using a confocal microscope (FV10i, Olympus, Tokyo) [
9,
10].
4.11. Statistical Analysis
Statistical significance was assessed using one-way analysis of variance or Student’s t-test (paired or unpaired), as appropriate. Differences were considered significant for p-values < 0.05. The results are expressed as the means ± SD.
Figure 1.
Expression of CA mRNA. The expressions of CAI, CAII, CAIII, CAIV, and CAVb were examined using RT-PCR. (A) c-hNECs. (B) c-hBECs. CAIV was expressed in c-hNECs, but not in c-hBECs. (C) The Real-Time PCR examination of CAIV mRNA in c-hNECs and c-hBECs. The expression level of CAIV mRNA was significantly higher in c-hNEC than in c-hBECs. * indicates significant difference (p < 0.01).
Figure 1.
Expression of CA mRNA. The expressions of CAI, CAII, CAIII, CAIV, and CAVb were examined using RT-PCR. (A) c-hNECs. (B) c-hBECs. CAIV was expressed in c-hNECs, but not in c-hBECs. (C) The Real-Time PCR examination of CAIV mRNA in c-hNECs and c-hBECs. The expression level of CAIV mRNA was significantly higher in c-hNEC than in c-hBECs. * indicates significant difference (p < 0.01).
Figure 2.
Western blotting for CAIV in c-hNECs and c-hBECs. (A) The single band of CAIV (40 kDa) was detected in c-hNECs but was faint in c-hBECs. (B) Densitometric analysis. The expression of CAIV protein was higher in c-hNECS (n = 4) than in c-hBECs (n = 4). * indicates significant difference (p < 0.01).
Figure 2.
Western blotting for CAIV in c-hNECs and c-hBECs. (A) The single band of CAIV (40 kDa) was detected in c-hNECs but was faint in c-hBECs. (B) Densitometric analysis. The expression of CAIV protein was higher in c-hNECS (n = 4) than in c-hBECs (n = 4). * indicates significant difference (p < 0.01).
Figure 3.
Immunofluorescence examination for CAIV. (A) c-hNEC. A1: CAIV, A2: AC-tubulin (a cilia marker), A3: merged image, A4: phase contrast image. The cilia of c-hNEC were immunopositively stained for CAIV. (B) c-hBEC. B1: CAIV, B2: AC-tubulin, B3: merged image, B4: phase contrast image. The cilia of c-hBECs were not stained for CAIV.
Figure 3.
Immunofluorescence examination for CAIV. (A) c-hNEC. A1: CAIV, A2: AC-tubulin (a cilia marker), A3: merged image, A4: phase contrast image. The cilia of c-hNEC were immunopositively stained for CAIV. (B) c-hBEC. B1: CAIV, B2: AC-tubulin, B3: merged image, B4: phase contrast image. The cilia of c-hBECs were not stained for CAIV.
Figure 4.
NBC expression (A,B) and AE expression (C, D) in c-hNECs and c-hBECs. The mRNA of both HCO3- transporters was detected using RT-PCR. (A) c-hNECS. NBC1, NBCe1, NBCe2 and NBCn1, but not NCBE, were expressed. (B) c-hBECs. NBC1, NBCe1, NBCe2 and NBCn1, but not NCBE, were expressed. (C) c-hNECs. SLC4A2 was expressed, but SLC26A4, SLC26A6, SLC26A9 and SLC4A3 were not. (D) c-hBECs. SLC4A2 was expressed, but SLC26A4, SLC26A6, SLC26A9 and SLC4A3 were not. There is no difference in the mRNA expression of NBCs or AEs between c-hNECs and c-hBECs.
Figure 4.
NBC expression (A,B) and AE expression (C, D) in c-hNECs and c-hBECs. The mRNA of both HCO3- transporters was detected using RT-PCR. (A) c-hNECS. NBC1, NBCe1, NBCe2 and NBCn1, but not NCBE, were expressed. (B) c-hBECs. NBC1, NBCe1, NBCe2 and NBCn1, but not NCBE, were expressed. (C) c-hNECs. SLC4A2 was expressed, but SLC26A4, SLC26A6, SLC26A9 and SLC4A3 were not. (D) c-hBECs. SLC4A2 was expressed, but SLC26A4, SLC26A6, SLC26A9 and SLC4A3 were not. There is no difference in the mRNA expression of NBCs or AEs between c-hNECs and c-hBECs.
Figure 5.
Changes in CBF, CBD and pHi in c-hNECs upon applying the CO2/HCO3--free solution (Zero-CO2). (A) Changes in CBF and CBD ratios. Application of Zero-CO2 induced a small transient increase followed by a gradual decrease in CBF or CBD. (B) Changes in pHi. Application of Zero-CO2 gradually decreased the pHi from 7.65 to 7.30.
Figure 5.
Changes in CBF, CBD and pHi in c-hNECs upon applying the CO2/HCO3--free solution (Zero-CO2). (A) Changes in CBF and CBD ratios. Application of Zero-CO2 induced a small transient increase followed by a gradual decrease in CBF or CBD. (B) Changes in pHi. Application of Zero-CO2 gradually decreased the pHi from 7.65 to 7.30.
Figure 6.
Changes in CBF and pHi induced by an NH4+ pulse in c-hNECs. (A) Changes in CBF upon applying an NH4+ pulse in the Zero-CO2. The application of Zero-CO2 slightly increased the CBF, but its increase was not significant. The NH4+ pulse induced an immediate increase followed by a gradual decrease in CBF. The cessation of NH4+ pulse immediately decreased the CBF. (B) Changes in CBF induced by the NH4+ pulse in the control solution. The application of NH4+ pulse induced an immediate increase followed by a gradual decrease in CBF. Cessation of the NH4+ pulse immediately decreased the CBF. (C) Changes in pHi upon applying the NH4+ pulse. The NH4+ pulse induced an immediate increase followed by a gradual decrease in pHi. Cessation of the NH4+ pulse immediately decreased the pHi, and the pHi then gradually increased to the control level.
Figure 6.
Changes in CBF and pHi induced by an NH4+ pulse in c-hNECs. (A) Changes in CBF upon applying an NH4+ pulse in the Zero-CO2. The application of Zero-CO2 slightly increased the CBF, but its increase was not significant. The NH4+ pulse induced an immediate increase followed by a gradual decrease in CBF. The cessation of NH4+ pulse immediately decreased the CBF. (B) Changes in CBF induced by the NH4+ pulse in the control solution. The application of NH4+ pulse induced an immediate increase followed by a gradual decrease in CBF. Cessation of the NH4+ pulse immediately decreased the CBF. (C) Changes in pHi upon applying the NH4+ pulse. The NH4+ pulse induced an immediate increase followed by a gradual decrease in pHi. Cessation of the NH4+ pulse immediately decreased the pHi, and the pHi then gradually increased to the control level.
Figure 7.
Effects of dorzolamide (an inhibitor of CAII and CAIV) and brinzolamide (a selective inhibitor of CAII) on CBF and pHi in c-hNECs. (A) Effects of dorzolamide (1 µM) on CBF upon applying Zero-CO2. Dorzolamide abolished the CBF decrease induced by applying Zero-CO2. (B) Effects of brinzolamide (0.1 µM) on CBF upon applying Zero-CO2. The addition of brinzolamide abolished the CBF decrease induced by applying the CO2/HCO3--free solution. (C) Effects of brinzolamide on CBF changes induced by the NH4+ pulse. In the presence of brinzolamide, the application of NH4+ pulse induced an immediate increase followed by a gradual increase in CBF. Brinzolamide induced a gradual increase in CBF, without any decrease, during the NH4+ pulse. Cessation of the NH4+ pulse immediately decreased the CBF. (D) Effects of brinzolamide on pHi changes induced by the NH4+ pulse. Brinzolamide alone did not change the pHi. The subsequent application of NH4+ pulse induced an immediate increase followed by a slight decrease in pHi. Cessation of the NH4+ pulse immediately decreased the pHi, and the pHi then increased gradually to a control value.
Figure 7.
Effects of dorzolamide (an inhibitor of CAII and CAIV) and brinzolamide (a selective inhibitor of CAII) on CBF and pHi in c-hNECs. (A) Effects of dorzolamide (1 µM) on CBF upon applying Zero-CO2. Dorzolamide abolished the CBF decrease induced by applying Zero-CO2. (B) Effects of brinzolamide (0.1 µM) on CBF upon applying Zero-CO2. The addition of brinzolamide abolished the CBF decrease induced by applying the CO2/HCO3--free solution. (C) Effects of brinzolamide on CBF changes induced by the NH4+ pulse. In the presence of brinzolamide, the application of NH4+ pulse induced an immediate increase followed by a gradual increase in CBF. Brinzolamide induced a gradual increase in CBF, without any decrease, during the NH4+ pulse. Cessation of the NH4+ pulse immediately decreased the CBF. (D) Effects of brinzolamide on pHi changes induced by the NH4+ pulse. Brinzolamide alone did not change the pHi. The subsequent application of NH4+ pulse induced an immediate increase followed by a slight decrease in pHi. Cessation of the NH4+ pulse immediately decreased the pHi, and the pHi then increased gradually to a control value.
Figure 8.
Effects of NBC inhibitors (S0859 and DIDS) on CBF and pHi in c-hNECs. (A) S0859 (30 µM). The addition of S0859 decreased the CBF. The removal of S0859 increased the CBF to a control level. (B) DIDS (200 µM). The addition of DIDS decreased the CBF. However, the removal of DIDS did not recover the CBF. (C) Effects of S0859 on pHi. The addition of S0859 gradually decreased the pHi, the removal of S0859 increased the pHi, and the pHi then decreased gradually.
Figure 8.
Effects of NBC inhibitors (S0859 and DIDS) on CBF and pHi in c-hNECs. (A) S0859 (30 µM). The addition of S0859 decreased the CBF. The removal of S0859 increased the CBF to a control level. (B) DIDS (200 µM). The addition of DIDS decreased the CBF. However, the removal of DIDS did not recover the CBF. (C) Effects of S0859 on pHi. The addition of S0859 gradually decreased the pHi, the removal of S0859 increased the pHi, and the pHi then decreased gradually.
Figure 9.
Effects of S0859 on CBF. (A) Prior treatment of brinzolamide. In the presence of brinzolamide, the addition of S0859 did not change CBF in c-hNECs. (B) The c-hNECs were treated with S0859 for 1 hr. The application of Zero-CO2 transiently increased the CBF in c-hNECs.
Figure 9.
Effects of S0859 on CBF. (A) Prior treatment of brinzolamide. In the presence of brinzolamide, the addition of S0859 did not change CBF in c-hNECs. (B) The c-hNECs were treated with S0859 for 1 hr. The application of Zero-CO2 transiently increased the CBF in c-hNECs.
Figure 10.
Effects of Zero-CO2 and the NH4+ pulse on CBF, CBD and pHi in c-hBECs. (A) Application of Zero-CO2 transiently increased the CBF and CBD in c-hBECs. (B) Application of Zero-CO2 transiently increased the pHi in c-hBECs. (C) Application of the NH4+ pulse in the control solution increased and plateaued CBF. Cessation of the NH4+ pulse decreased the CBF. (D) Application of the NH4+ pulse immediately increased and plateaued the pHi without any decrease. Cessation of the NH4+ pulse decreased the pHi and then gradually increased to a control level.
Figure 10.
Effects of Zero-CO2 and the NH4+ pulse on CBF, CBD and pHi in c-hBECs. (A) Application of Zero-CO2 transiently increased the CBF and CBD in c-hBECs. (B) Application of Zero-CO2 transiently increased the pHi in c-hBECs. (C) Application of the NH4+ pulse in the control solution increased and plateaued CBF. Cessation of the NH4+ pulse decreased the CBF. (D) Application of the NH4+ pulse immediately increased and plateaued the pHi without any decrease. Cessation of the NH4+ pulse decreased the pHi and then gradually increased to a control level.
Figure 11.
Effects of brinzolamide and S0859 on CBF and pHi in c-hBECs. (A) The addition of brinzolamide gradually decreased the CBF, and then, application of the NH4+ pulse increased and plateaued CBF. Cessation of the NH4+ pulse decreased the CBF. (B) The addition of brinzolamide (0.1 µM) gradually decreased the pHi, and the NH4+ pulse then increased and plateaued the pHi. Cessation of the NH4+ pulse decreased the pHi. (C) The addition of S0859 slightly increased the CBF (not significant). Removing S0859 gradually increased the CBF. (D) The addition of S0859 did not change the pHi. Removing S0859 slightly increased the pHi.
Figure 11.
Effects of brinzolamide and S0859 on CBF and pHi in c-hBECs. (A) The addition of brinzolamide gradually decreased the CBF, and then, application of the NH4+ pulse increased and plateaued CBF. Cessation of the NH4+ pulse decreased the CBF. (B) The addition of brinzolamide (0.1 µM) gradually decreased the pHi, and the NH4+ pulse then increased and plateaued the pHi. Cessation of the NH4+ pulse decreased the pHi. (C) The addition of S0859 slightly increased the CBF (not significant). Removing S0859 gradually increased the CBF. (D) The addition of S0859 did not change the pHi. Removing S0859 slightly increased the pHi.
Figure 12.
Schematic diagrams of CBF and pHi regulation by CAIV in c-hNEC (A): ALI culture. CO2 (5%) supplied from the culture gas is converted to HCO3- and H+ by CAIV. The HCO3- transport metabolon (CAIV, NBC and CAII) maximizes the rate of HCO3- entry in c-hNECs cultured by the ALI. The HCO3- entry into cells traps H+ and is converted to CO2 by CAII, leading to an extremely high pHi in c-hNECs. (B): In vivo. CO2, which is leaked from the interstitial fluid (5%) to the apical surface (0.04%), is converted to H+ and HCO3- by CAIV. H+ stays in the surface mucous layer. The HCO3- enters cell via the HCO3- transport metabolon. The HCO3- that entered the cells, which is removed by CAII, maintains adequate pHi and CBF levels in c-hNECs exposed to air (0.04% CO2). At present, we do not know the exact pHi of c-hNECs in vivo.
Figure 12.
Schematic diagrams of CBF and pHi regulation by CAIV in c-hNEC (A): ALI culture. CO2 (5%) supplied from the culture gas is converted to HCO3- and H+ by CAIV. The HCO3- transport metabolon (CAIV, NBC and CAII) maximizes the rate of HCO3- entry in c-hNECs cultured by the ALI. The HCO3- entry into cells traps H+ and is converted to CO2 by CAII, leading to an extremely high pHi in c-hNECs. (B): In vivo. CO2, which is leaked from the interstitial fluid (5%) to the apical surface (0.04%), is converted to H+ and HCO3- by CAIV. H+ stays in the surface mucous layer. The HCO3- enters cell via the HCO3- transport metabolon. The HCO3- that entered the cells, which is removed by CAII, maintains adequate pHi and CBF levels in c-hNECs exposed to air (0.04% CO2). At present, we do not know the exact pHi of c-hNECs in vivo.
Table 1.
Primers used to amplify CA.
Table 1.
Primers used to amplify CA.
Transcript |
Direction |
Sequence |
Size (bp) |
CA1 |
Sense |
AGCTGCCTCAAAGGCTGATG |
181 |
Antisense |
GGTCCAGAAATCCAGGGATGAA |
CA2 |
Sense |
TTACTGGACCTACCCAGGCTCAC |
167 |
Antisense |
GCCAGTTGTCCACCATCAGTTC |
CA3 |
Sense |
CATGAGAATGGCGACTTCCAGA |
141 |
Antisense |
GAATGAGCCCTGGTAGGTCCAGTA |
CA4 |
Sense |
TCCCTAGAAACCTAGGGTCATTTCA |
156 |
Antisense |
TGGAGCTAGATCACGTTTCACAA |
CA5b |
Sense |
TGTTCTGAAGTGAAAGTCTGGTCTG |
172 |
Antisense |
CCAAACTAGAGTGCCCTGGATG |
Table 2.
Primers used to amplify NBCs and AEs.
Table 2.
Primers used to amplify NBCs and AEs.
NBC |
Transcript |
Direction |
Sequence |
Size (bp) |
NCBE (SLC4A10) |
Sense |
GCAGGTCAGGTTGTTTCTCCTC |
498 |
Antisense |
TCTTCCTCTTCTCCTGGGAAGG |
NBC1 (SLC4A11) |
Sense |
GGCCTGTGGAACAGTTTCTTCC |
690 |
Antisense |
TGCCCTTCACCAGCCTGTTCTC |
NBCe1 (SLC4A4) |
Sense |
GGTGTGCAGTTCATGGATCGTC |
336 |
Antisense |
GTCACTGTCCAGACTTCCCTTC |
NBCe2 (SLC4A5) |
Sense |
ATCTTCATGGACCAGCAGATCAC |
468 |
Antisense |
TGCTTGGCTGGCATCAGGAGG |
NBCn1 (SLC4A7) |
Sense |
CAGATGCAAGCAGCCTTGTGTG |
328 |
Antisense |
GGTCCATGATGACCACAAGCTG |
NDCBE1 (SLC4A8) |
Sense |
GCTCAAGAAAGGCTGTGGCTAC |
243 |
Antisense |
CATGAAGACTGAGCAGCCCATC |
AE |
AE2 |
Sense |
GAAGATTCCTGAGAATGCCT |
181 |
Antisense |
GTCCATGTTGGCAGTAGTCG |
AE3 |
Sense |
ATCTGAGGCAGAACCTGTGG |
418 |
Antisense |
TTTCACTAAGTGTCGCCGC |
SLC26A4 |
Sense |
GTTTACTAGCTGGCCTTATATTTGGACTGT |
484 |
Antisense |
AGGCTATGGATTGGCACTTTGGGAACG |
SLC26A6 |
Sense |
TAGGGGAGGTTGGGCCAGGGATGC |
456 |
Antisense |
TGCCGGGAAGTGCCAAACAGGAAGAAGTAGAT |
SLC26A9 |
Sense |
TCCAGGTCTTCAACAATGCCAC |
400 |
Antisense |
CGAGTCTTGTGCATGTAGCGAG |